Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets.
Samer El KababjiNicholas MitsakakisXi FangAna-Alicia Beltran-BlessGreg PondLisa VandermeerDhenuka RadhakrishnanLucy MosqueraAlexander PatersonLois E ShepherdBingshu E ChenWilliam E BarlowJulie R GralowMarie-France SavardMark J ClemonsKhaled El EmamPublished in: JCO clinical cancer informatics (2023)
Synthetic data using sequential synthesis methods can act as a proxy for real clinical trial data sets, and simultaneously have low privacy risks. This type of generative model can be one way to enable broader sharing of clinical trial data.